The Pharma Data

JANUARY 7, 2021

This clearance is a pivotal regulatory milestone that further supports Camallergy’s leadership and capabilities in the field of peanut allergy immunotherapy with the only cGMP-certified manufacturing facility in Europe producing peanut oral immunotherapy,” said Sherden Timmins, Chief Technology Officer. About Camallergy.

Allergies 52

Allergies Manufacturing Production Clinical Trials 52

The Pharma Data

APRIL 3, 2021

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. About the ITAC Trial.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

Scienmag

APRIL 21, 2021

Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The therapeutic […].

Antibody 81

Antibody Clinical Trials Clinical Trials Trials 81

World of DTC Marketing

OCTOBER 6, 2021

government $712 for the same amount of medicine or 40 times the price. Like the vast majority of medicines on the market, molnupiravir — which was originally investigated as a possible treatment for Venezuelan equine encephalitis — was developed using government funds. million for NIH-funded clinical trials.

Clinical Trials 198

Clinical Trials Clinical Trials Allergies Trials 198

Scienmag

MAY 25, 2021

May 25, 2021 — Critical Path Institute (C-Path) today announced its schedule for the Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Workshop, to be held virtually June 15-16. Together […].

Clinical Trials 73

Clinical Trials Clinical Trials Trials Development 73

The Pharma Data

AUGUST 7, 2020

The governing body claims this proposal could have positive effects on mitigating burdensome requirements for gene therapy clinical trials in the future. In this light, Pharma IQ’s weekly round-up focuses on advancing therapies and clinical trials to combat Covid-19.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Trials 52

Scienmag

DECEMBER 11, 2020

Peer-reviewed results of NIH clinical trial published Credit: NIAID WHAT: The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.

Allergies 53

Allergies Clinical Trials Clinical Trials Medicine 53

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Production 162

Production Regulation Clinical Trials Clinical Trials 162

Pharmaceutical Technology

JUNE 10, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Taiho Pharmaceutical overview Taiho Pharmaceutical (Taiho), a subsidiary of Otsuka Group, develops and markets pharmaceutical products in the field of cancer, immunology, allergy and urology.

Allergies 100

Allergies Production Clinical Trials Clinical Trials 100

Pharmaceutical Technology

JUNE 10, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Taiho Pharmaceutical overview Taiho Pharmaceutical (Taiho), a subsidiary of Otsuka Group, develops and markets pharmaceutical products in the field of cancer, immunology, allergy and urology.

Allergies 100

Allergies Production Clinical Trials Clinical Trials 100

XTalks

JULY 6, 2022

Their 48-month clinical study has revealed that VivAer can substantially ease the symptoms of NVC and improve nasal breathing. The four-year results from the VivAer clinical trial were published in the International Forum of Allergy & Rhinology.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Allergies 52

Scienmag

MAY 21, 2021

The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021). Results of the clinical trial at […].

Clinical Trials 43

Clinical Trials Clinical Trials Trials Research 43

The Pharma Data

MARCH 31, 2022

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. Vaccine manufacturers have previously studied some variant vaccine candidates and are currently conducting clinical trials of Omicron-specific vaccines. Nadine Rouphael, M.D.,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Immune Response 52

The Pharma Data

MAY 22, 2023

DUPIXENT® (DUPILUMAB) LATE-BREAKING PHASE 3 COPD RESULTS PRESENTED AT ATS AND SIMULTANEOUSLY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Regeneron Pharmaceuticals, Inc. The Dupixent Phase 3 results were presented in the 2023 American Thoracic Society (ATS) International Conference session “New England Journal of Medicine and JAMA.

Medicine 52

Medicine Allergies Trials Clinical Trials 52

The Pharma Data

NOVEMBER 16, 2020

and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The same DSMB also oversees the additional OWS-supported Phase 3 clinical trials evaluating COVID-19 vaccine candidates. principal investigator and medical director of Meridian Clinical Research. Baden, M.D.,

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Scienmag

NOVEMBER 12, 2020

Peer-reviewed / Randomised Controlled Trial / People Inhaled delivery of a formulation of a key […].

Immune Response 75

Immune Response Protein Clinical Trials Clinical Trials 75

Scienmag

OCTOBER 5, 2020

Michael Houghton discovered hepatitis C virus and now is developing a vaccine Credit: Photo: Michael Holly Michael Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine today in recognition of his discovery of the hepatitis C (HCV) virus.

Medicine 86

Medicine Vaccination Vaccine Development 86

Scienmag

SEPTEMBER 8, 2020

million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials. Following successful completion […].

Clinical Trials 45

Clinical Trials Clinical Trials Trials Vaccination 45

Drug Discovery World

NOVEMBER 29, 2023

At sites in the US, Japan, and the EU, the clinical trial will evaluate the safety, tolerability, and efficacy of leniolisib in 15 children, one to six years of age, who have a confirmed APDS diagnosis.

Trials 52

Trials Clinical Trials Clinical Trials Allergies 52

Scienmag

APRIL 2, 2021

By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus’ ability to infect cell lines; clinical trials are underway Credit: National Institute of Allergy and Infectious Diseases, NIH James McKerrow, MD, PhD, dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long (..)

Allergies 53

Allergies Pharmacy Clinical Trials Clinical Trials 53

XTalks

SEPTEMBER 21, 2023

The trial’s primary objective is to assess the safety of VIR-1388 and its capacity to stimulate a specific immune response against HIV in study participants. This groundbreaking endeavor has received support from the National Institute of Allergy and Infectious Diseases (NIAID).

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

Scienmag

NOVEMBER 30, 2020

– The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, has been re-funded for the next seven years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and collaborating NIH Institutes. Los Angeles, Calif. M.Sc, […].

Allergies 41

Allergies Clinical Trials Clinical Trials Trials 41

Scienmag

APRIL 29, 2021

Now, in two related papers published April 28, 2021 in Science Translational Medicine, researchers at UCSF have demonstrated how to engineer […].

Clinical Trials 46

Clinical Trials Clinical Trials Engineer Trials 46

Velocity Clinical Research

JANUARY 3, 2024

The acquisition of KO-MED is Velocity’s first foray into Oncology research, which accounts for roughly 40-50% of clinical trials globally. KO-MED has been the leading multi-site network in Poland since 2020, having enrolled over 9,000 patients into clinical research. and Europe.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

Pharmaceutical Technology

APRIL 26, 2023

There is also increasing data from large-scale randomised clinical trials demonstrating their impact on improving asthma outcomes,” says Dr. Giselle Mosnaim, clinical associate professor at the University of Chicago Pritzker School of Medicine.

Clinical Trials 289

Clinical Trials Clinical Trials Allergies Research 289

Scienmag

SEPTEMBER 30, 2020

Age and underlying health conditions also associated with decreased survival Credit: Justin Kelley Clinical trials are testing whether medications that treat human immunodeficiency virus (HIV) can also treat COVID-19, leading some patients with HIV to believe they might be protected against the coronavirus.

Clinical Trials 94

Clinical Trials Clinical Trials Medicine Trials 94

Scienmag

AUGUST 11, 2020

Baylor Scott & White Research Institute becomes first site in the world to conduct new trial testing experimental monoclonal antibodies as a treatment for hospitalized COVID-19 patients Credit: Baylor Scott & White Research Institute DALLAS, Texas – On Wednesday, August 5, in Dallas, just one day after the initiative was launched by (..)

Clinical Trials 52

Clinical Trials Clinical Trials Trials Antibody 52

XTalks

SEPTEMBER 8, 2020

AZD1222 is now in Phase III clinical trials which will enroll approximately 30,000 adult volunteers in 80 states in the US, to determine whether the vaccine can help prevent symptomatic coronavirus disease from spreading. “Our AstraZeneca, a UK-based global pharmaceutical company, is leading the COVID-19 trial as a regulatory sponsor.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

XTalks

DECEMBER 20, 2022

In the United States, we are a leading manufacturer of small-molecule injectable medicines. Register for this free webinar to learn about drug testing in humanized mouse models in two therapeutic areas: food allergy and inflammatory bowel diseases (IBD). Why is Idacio a Cost-Effective Drug?

FDA Approval 98

FDA Approval Allergies Manufacturing Clinical Trials 98

Scienmag

FEBRUARY 10, 2021

Discovery paves way to precision medicine for prostate cancer in all races Increased level of plasma cells linked to improved cancer survival 1,300 prostate tumor samples studied Immunotherapy-based precision medicine clinical trials being developed CHICAGO— Black men die more often of prostate cancer yet, paradoxically, have greater survival (..)

Clinical Trials 40

Clinical Trials Clinical Trials Medicine Trials 40

Druggist

DECEMBER 28, 2020

First-generation antihistamines can also be used to help manage allergies. When taken correctly, fexofenadine is unlikely to cause harmful side effects or interact with other medicines. Taking Allevia tablets with other medicines. Customers who seek for over the counter antihistamines have an excellent choice of medicines.

Pharmacy 98

Pharmacy Doctors Doctor Allergies 98

Scienmag

OCTOBER 14, 2020

A prospective observational study testing the concept of trained immunity for protection from severe COVID-19 reported milder symptoms in COVID patients receiving MMR vaccination, as published in Allergy. Credit: Centro de Excelencia en Asma y Alergia COVID-19 continues to wreak havoc globally, with over one million deaths to date.

Vaccination 59

Vaccination Vaccine Allergies Clinical Trials 59

pharmaphorum

JULY 28, 2022

Dupixent’s march towards becoming one of the world’s top-selling medicines continued at a healthy lick in the second quarter, allowing Sanofi to raise its full-year earnings forecasts. Development in peanut allergy has also been discontinued, said Sanofi in its second-quarter update.

Sales 59

Sales Allergies Vaccination Vaccine 59

Scienmag

AUGUST 12, 2020

American Journal of Pathology publishes efficacy results from Houston Methodist clinical trial Credit: Houston Methodist HOUSTON-(Aug. The results, which appear now in The American […].

Clinical Trials 95

Clinical Trials Clinical Trials Trials Allergies 95

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. In a second phase, doses are then taken at home and raised gradually over at least 22 weeks, with a clinic visit required at each dose increase.

Allergies 124

Allergies Drugs Clinical Trials Clinical Trials 124

Scienmag

MAY 11, 2021

Study shows treatment developed by international team restored immune function in more than 95% of patients in three clinical trials Credit: Ann Johansson/UCLA Broad Stem Cell Research Center An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 (..)

Gene Therapy 78

Gene Therapy Gene Clinical Trials Clinical Trials 78

Scienmag

OCTOBER 25, 2020

Latest results from KRYSTAL-1 early clinical trial of adagrasib (MRTX849) Credit: Pasi A. Jänne New results from early clinical trials of a drug that targets a cancer-causing mutation in the KRAS gene have shown that it can shrink tumours and is well-tolerated by patients.

Gene 53

Gene Clinical Trials Clinical Trials Trials 53